Dr. Patel defines LEMS as a neuromuscular disorder in which the synapses between nerve and muscle stop firing properly.
CORAL GABLES, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
An NCDB analysis on the demographic, treatment, and survival of nonkeratinizing small cell squamous cell carcinoma. Beyond-line immunotherapy in ES-SCLC: Efficacy and safety of second-line PD-1/PD-L1 ...
Different Impact of Excision Repair Cross-Complementation Group 1 on Survival in Male and Female Patients With Inoperable Non–Small-Cell Lung Cancer Treated With Carboplatin and Gemcitabine SOX1 ...
LEMS is an autoimmune disorder linked to SCLC, causing muscle weakness and autonomic dysfunction due to presynaptic calcium channel antibodies. Differentiation from myasthenia gravis involves ...
CORAL GABLES, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric ...
VGCC antibody testing in conjunction with neurologic consultation can diagnose LEMS Amifampridine may be considered as a supportive care treatment Guideline inclusion may raise clinical awareness of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results